星空体育官方入口网站网址大全-登录入口官网

#药物临床试验#

70篇内容 | 1897人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1480952, encodeId=eb6c14809523d, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=新规来了！药物临床试验期间方案变更技术指导原则（试行）, objectType=article, longId=730717, objectId=54ebe3071773, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54ebe3071773, replyNumber=0, likeNumber=85, createdTime=2022-06-29, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54ebe3071773, moduleTitle=新规来了！药物临床试验期间方案变更技术指导原则（试行）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=54ebe3071773)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480951, encodeId=dee6148095149, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=指南推荐：体重控制药物临床试验技术指导原则, objectType=article, longId=291930, objectId=66a4291930d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66a4291930d1, replyNumber=0, likeNumber=51, createdTime=2021-12-17, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66a4291930d1, moduleTitle=指南推荐：体重控制药物临床试验技术指导原则, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=66a4291930d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480950, encodeId=f0a214809503f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=CDE发布《药物临床试验中心化监查统计指导原则（征求意见稿）》公开征求意见通知, objectType=article, longId=217255, objectId=cbb821e255b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbb821e255b0, replyNumber=0, likeNumber=73, createdTime=2021-09-19, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbb821e255b0, moduleTitle=CDE发布《药物临床试验中心化监查统计指导原则（征求意见稿）》公开征求意见通知, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=cbb821e255b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480949, encodeId=cb6614809491f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=因明生物完成近5000万美元A+轮融资，加速重磅管线候选药物临床试验, objectType=article, longId=217044, objectId=c32221e04412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c32221e04412, replyNumber=0, likeNumber=69, createdTime=2021-09-15, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c32221e04412, moduleTitle=因明生物完成近5000万美元A+轮融资，加速重磅管线候选药物临床试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c32221e04412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480948, encodeId=aa1c14809488b, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, objectType=article, longId=209942, objectId=434e20994255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434e20994255, replyNumber=0, likeNumber=64, createdTime=2021-04-15, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434e20994255, moduleTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=434e20994255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480947, encodeId=d6a7148094ea6, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=药物临床试验中不良事件的案例收集与评判, objectType=article, longId=206897, objectId=ae7020689ec2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae7020689ec2, replyNumber=0, likeNumber=90, createdTime=2021-02-08, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae7020689ec2, moduleTitle=药物临床试验中不良事件的案例收集与评判, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ae7020689ec2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480946, encodeId=afc01480946a5, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=知临集团宣布提交ALS-4——一种用于治疗由金黄色葡萄球菌引起感染的口服的小分子药物临床试验申请, objectType=article, longId=204778, objectId=aac0204e78e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aac0204e78e1, replyNumber=0, likeNumber=63, createdTime=2020-12-24, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aac0204e78e1, moduleTitle=知临集团宣布提交ALS-4——一种用于治疗由金黄色葡萄球菌引起感染的口服的小分子药物临床试验申请, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=aac0204e78e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480945, encodeId=359c1480945a7, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=CDE发布：药物临床试验适应性设计指导原则（征求意见稿）, objectType=article, longId=204258, objectId=620020425818, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=620020425818, replyNumber=0, likeNumber=63, createdTime=2020-12-09, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=620020425818, moduleTitle=CDE发布：药物临床试验适应性设计指导原则（征求意见稿）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=620020425818)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480944, encodeId=b051148094420, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=Aging：3个月，细胞年轻25岁！首次非药物临床试验证明：逆转衰老，或许仅需换换氧, objectType=article, longId=203718, objectId=a349203e1892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a349203e1892, replyNumber=0, likeNumber=69, createdTime=2020-11-26, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a349203e1892, moduleTitle=Aging：3个月，细胞年轻25岁！首次非药物临床试验证明：逆转衰老，或许仅需换换氧, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a349203e1892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480943, encodeId=1416148094314, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=药物临床试验创新技术研究青年委员会成立大会及第一次学术会议暨安徽省药监局2020版药物临床试验质量管理规范培训班, objectType=article, longId=203502, objectId=21e620350266, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21e620350266, replyNumber=0, likeNumber=0, createdTime=2020-11-19, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21e620350266, moduleTitle=药物临床试验创新技术研究青年委员会成立大会及第一次学术会议暨安徽省药监局2020版药物临床试验质量管理规范培训班, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=21e620350266)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480942, encodeId=1a3914809427e, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=安徽省药监局2020年第1期2020版药物临床试验质量管理规范培训班暨GCP联盟药物临床试验创新技术研究青年委员会成立大会及第一次学术会议直播预告, objectType=article, longId=202979, objectId=487d2029e958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=487d2029e958, replyNumber=0, likeNumber=62, createdTime=2020-11-08, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=487d2029e958, moduleTitle=安徽省药监局2020年第1期2020版药物临床试验质量管理规范培训班暨GCP联盟药物临床试验创新技术研究青年委员会成立大会及第一次学术会议直播预告, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=487d2029e958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480941, encodeId=3ad41480941af, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=39个药物临床试验项目的文档管理规范化总结, objectType=article, longId=202852, objectId=ac54202852a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac54202852a2, replyNumber=0, likeNumber=69, createdTime=2020-11-05, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac54202852a2, moduleTitle=39个药物临床试验项目的文档管理规范化总结, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ac54202852a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480940, encodeId=a9e91480940cf, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=药物临床试验受试者隐私保护的有关伦理问题及其研究进展, objectType=article, longId=202610, objectId=1408202610ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1408202610ce, replyNumber=0, likeNumber=79, createdTime=2020-10-31, rootId=0, userName=1508842480_96220439, userId=65ed7724096, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1408202610ce, moduleTitle=药物临床试验受试者隐私保护的有关伦理问题及其研究进展, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1408202610ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480939, encodeId=cd79148093980, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=快看！新的药物临床试验核查要点与判定原则要来了！核查中心周五重磅发布意见稿, objectType=article, longId=194628, objectId=c49819462835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c49819462835, replyNumber=0, likeNumber=76, createdTime=2020-05-25, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c49819462835, moduleTitle=快看！新的药物临床试验核查要点与判定原则要来了！核查中心周五重磅发布意见稿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c49819462835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480938, encodeId=9a1b14809386f, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=关于对ICH E6（R2）《药物临床试验管理规范》修订工作开展问卷调查的通知, objectType=article, longId=194411, objectId=5c7c194411c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c7c194411c0, replyNumber=0, likeNumber=55, createdTime=2020-05-21, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c7c194411c0, moduleTitle=关于对ICH E6（R2）《药物临床试验管理规范》修订工作开展问卷调查的通知, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c7c194411c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480937, encodeId=a210148093ed1, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, objectType=article, longId=194212, objectId=13c2194212aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2194212aa, replyNumber=0, likeNumber=71, createdTime=2020-05-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2194212aa, moduleTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=13c2194212aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480936, encodeId=b6901480936c4, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=关于公开征求《药物临床试验适应性设计指导原则》意见的通知, objectType=article, longId=194211, objectId=040c19421122, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=040c19421122, replyNumber=0, likeNumber=76, createdTime=2020-05-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=040c19421122, moduleTitle=关于公开征求《药物临床试验适应性设计指导原则》意见的通知, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=040c19421122)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480935, encodeId=bfea1480935ea, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=NMPA发布疫情期间药物临床试验管理指导原则征求意见稿, objectType=article, longId=193558, objectId=04d019355837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04d019355837, replyNumber=0, likeNumber=68, createdTime=2020-05-07, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04d019355837, moduleTitle=NMPA发布疫情期间药物临床试验管理指导原则征求意见稿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=04d019355837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480934, encodeId=2e93148093468, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=修订版《药物临床试验质量管理规范》将于2020年7月1日正式实施, objectType=article, longId=193066, objectId=037f193066d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=037f193066d2, replyNumber=0, likeNumber=74, createdTime=2020-04-28, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=037f193066d2, moduleTitle=修订版《药物临床试验质量管理规范》将于2020年7月1日正式实施, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=037f193066d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1480933, encodeId=5d6a1480933b1, content=<a href='/topic/show?id=96a08e64833' target=_blank style='color:#2F92EE;'>#药物临床试验#</a>, objectTitle=抗肿瘤药物临床试验中风险评估与应对措施的探讨, objectType=article, longId=191066, objectId=430b191066c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=430b191066c8, replyNumber=0, likeNumber=63, createdTime=2020-03-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=430b191066c8, moduleTitle=抗肿瘤药物临床试验中风险评估与应对措施的探讨, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=430b191066c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药物临床试验

2020-05-29

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

新规来了！药物临床试验期间方案变更技术指导原则（试行）

2022-06-29

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

指南推荐：体重控制药物临床试验技术指导原则

2021-12-17

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

CDE发布《药物临床试验中心化监查统计指导原则（征求意见稿）》公开征求意见通知

2021-09-19

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

因明生物完成近5000万美元A+轮融资，加速重磅管线候选药物临床试验

2021-09-15

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则

2021-04-15

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

药物临床试验中不良事件的案例收集与评判

2021-02-08

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

知临集团宣布提交ALS-4——一种用于治疗由金黄色葡萄球菌引起感染的口服的小分子药物临床试验申请

2020-12-24

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

CDE发布：药物临床试验适应性设计指导原则（征求意见稿）

2020-12-09

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

Aging：3个月，细胞年轻25岁！首次非药物临床试验证明：逆转衰老，或许仅需换换氧

2020-11-26

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

药物临床试验创新技术研究青年委员会成立大会及第一次学术会议暨安徽省药监局2020版药物临床试验质量管理规范培训班

2020-11-19

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

安徽省药监局2020年第1期2020版药物临床试验质量管理规范培训班暨GCP联盟药物临床试验创新技术研究青年委员会成立大会及第一次学术会议直播预告

2020-11-08

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

39个药物临床试验项目的文档管理规范化总结

2020-11-05

1508842480_96220439 (审核中...)

前往app查看评论内容

#药物临床试验#

药物临床试验受试者隐私保护的有关伦理问题及其研究进展

2020-10-31

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

快看！新的药物临床试验核查要点与判定原则要来了！核查中心周五重磅发布意见稿

2020-05-25

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

关于对ICH E6（R2）《药物临床试验管理规范》修订工作开展问卷调查的通知

2020-05-21

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知

2020-05-17

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

关于公开征求《药物临床试验适应性设计指导原则》意见的通知

2020-05-17

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

NMPA发布疫情期间药物临床试验管理指导原则征求意见稿

2020-05-07

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

修订版《药物临床试验质量管理规范》将于2020年7月1日正式实施

2020-04-28

hb2008ye (审核中...)

前往app查看评论内容

#药物临床试验#

抗肿瘤药物临床试验中风险评估与应对措施的探讨

2020-03-31

科室
- - 订阅+
  - 更多科室
工具
服务